#AI twice as accurate as a #biopsy when grading severity of #sarcomas. Read more on this interesting story via PharmaTimes hubs.li/Q028w33f0

New #clinical trials underway to advance treatment of #PTSD. Clerkenwell Health, the mental health company has announced that it is taking part in a study evaluating the safety and efficacy of a drug in #patients with severe PTSD. hubs.li/Q028vZjH0

#Neurons aren't the only cells that make memories in the #brain, rodent study reveals. Blood-vessel-making #cells collaborate with neurons to form long-term memories in the mouse brain. Read more from Live Science hubs.li/Q028vWVc0

Book an RP Informs training session during which we will explore how our #SIMALTO trade-off methodology can advise your team on developing a product that will win on functionality, uniqueness, advocacy, and price. hubs.li/Q028vYpC0 #RPTraining

Sunday 12th November marked Diwali, the festival of lights. To celebrate, RP held a special Diwali lunch for all London employees. We hope everyone enjoyed the Diwali celebrations with loved ones last weekend!

Department of Health and Social Care (DHSC) has announced that 64 NHS trusts across England are set to deploy #AI tools to speed up the #diagnosis and #treatment of #lungcancer. Read more from PharmaTimes #LungCancerAwarenessMonth hubs.li/Q0296JLD0

Seven #digitalhealth technologies that could help millions of people with lower back #pain have been recommended for NHS in draft guidance published by cost-effectiveness overseer NICE. Find out more from pharmaphorum hubs.li/Q028vN9r0

Find out about our team of #emergingmarket experts with this infographic outlining our experience and expertise across a vast number of regions. Download your copy here now hubs.li/Q028vQ7y0

High #metabolism could be early sign of #Alzheimers disease - an early phase in the process of developing Alzheimer's disease is a metabolic increase in a part of the brain called the hippocampus, report researchers. hubs.li/Q028vWVk0

8k daily steps can reduce the risk of premature death - study identifies optimal number of steps which most people obtain greatest #health benefits, and also shows that the pace at which you walk provides additional benefits. hubs.li/Q028vZg10

RP would like to wish everyone a peaceful & joyous Thanksgiving. We want to express our gratitude to our clients, we're blessed to work with such incredible individuals who've trusted us with their business needs. We also want to thank our hard working colleagues in the US.

In this emotion #AI video, we look at how AI is revolutionizing the way in which we conduct #mrx. A wealth of information can be drawn from our facial expressions & vocal sentiment, which can be incredibly valuable for uncovering emotional insights. hubs.li/Q028vQJ50

#Menstrual cycle linked to structural changes across whole #brain via Live Science hubs.li/Q028vPNq0

A VR-based task could help differentiate people with #Alzheimers disease from the normal #cognitive impairment that occurs with age, according to a pilot study. Read more from pharmaphorum hubs.li/Q028vMLq0

In this recent article, we surveyed GPs and Payers from Research Partnership’s global payer network to find out how #AI is transforming the prescribing process and its impact on #patient outcomes and #healthcare costs. Read here now  hubs.li/Q028vNcc0

Find out how the imminent introduction of a new proposed price control methodology for patented #drugs at launch could potentially affect Colombia’s #pharmaceutical market attractiveness in this new article. Read the full article here hubs.li/Q028vPJH0

Did you know that 10% of the total population suffer from a form of #autoimmune disorder, with treatment costs reaching up to $50k annually for advanced therapies? Download our infographic to find out more hubs.li/Q02d3lN30

Season’s greetings from everyone at Research Partnership! In the spirit of giving back, and as a thank you to our clients and partners, we have made a donation to our chosen charity Forever Angels which supports children in need across Tanzania. #HappyHolidays #Pharma

PAH is a chronic and progressive condition that affects an estimated 15-50 individuals per million in the US. The new #TherapyWatch study is launching in the US market, with expansion into other geographies including Europe in early 2024. Read more here hubs.li/Q02d3gPp0

Have you seen our interactive #productlaunch infographic? If you are preparing your launch plan, or your research needs for 2024, download our interactive infographic to find out what market research is required when to answer your key business questions. hubs.li/Q02d3NKW0